BETA 2-MICROGLOBULIN - TUMOR MARKER - ANVISA Registration 80102513385

Access comprehensive regulatory information for BETA 2-MICROGLOBULIN - TUMOR MARKER in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80102513385 and manufactured by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until Mar 05, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
80102513385
2 Related Devices
Registration Details
ANVISA Registration Number: 80102513385
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Familia Maglumi ß2-microglobulina (CLIA)
Risk Class III

Registration Details

80102513385

25351409157202423

04718143000194

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Mar 05, 2025

05/03/2035

09/18/2025 19:00:01

Familia Maglumi ß2-microglobulina (CLIA)
Risk Class III

Registration Details

80102513385

25351409157202423

04718143000194

Dates and Status

Mar 05, 2025

05/03/2035

09/18/2025 19:00:01